The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for giving national guidance in the UK on the promotion of good health and the prevention and treatment of ill-health.
NICE guidance is developed using the expertise of the NHS and the wider healthcare community.
Latest Guidance from the National Institute for Health and Care Excellence (NICE):
- Endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstructions from cholangiocarcinoma or pancreatic adenocarcinoma (IPG464) – http://guidance.nice.org.uk/IPG464
- Irreversible electroporation for treating primary liver cancer – http://guidance.nice.org.uk/IPG444
- Irreversible electroporation for treating liver metastases –http://guidance.nice.org.uk/IPG445
- IRE for the treatment of pancreatic cancer – http://guidance.nice.org.uk/IPG442
- Colorectal cancer: the diagnosis and management of colorectal cancer – http://guidance.nice.org.uk/CG131
- Endoscopic transluminal pancreatic necrosectomy – http://guidance.nice.org.uk/IPG411
The guidance covers three areas of health:
- Clinical practice – guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS;
- Health technologies – guidance on the use of new and existing medicines, treatments and procedures within the NHS;
- Public health – guidance on the promotion of good health and the prevention of ill health for people working in the NHS, local authorities and the wider public and voluntary sectors.
- The NICE website – which contains all the guidance – can be found at www.nice.org.uk